Literature DB >> 12234900

Exertion of the suppressive effects of IFN-gamma on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase.

A Fukushima1, K Fukata, A Ozaki, M Takata, N Kuroda, H Enzan, H Ueno.   

Abstract

BACKGROUND/AIMS: Interferon gamma (IFN-gamma) knockout mice exhibit severe allergic conjunctivitis (AC), indicating that IFN-gamma regulates the development of AC. The authors examined whether this inhibitory effect of IFN-gamma is exerted during the induction or effector phase of experimental AC.
METHODS: Experimental immune mediated blepharoconjunctivitis (EC) was induced in Brown Norway (BN) rats, using ovalbumin (OVA) as the antigen. To investigate the role of IFN-gamma in the induction phase, EC was induced by active immunisation and IFN-gamma (10 micro g/time, total 70 micro g), or phosphate buffered saline (PBS) as a control, was injected intraperitoneally every other day from the day of immunisation. The rats were challenged with OVA eye drops 13 days after immunisation, and 24 hours later, the eyes were harvested for histology. To examine the effects of IFN-gamma in the effector phase, OVA specific T cells were transferred into syngeneic rats and IFN-gamma (10 micro g/time, total 50 micro g) or PBS was injected each day after the transfer until induction of EC 4 days later with an OVA challenge. To investigate the role of endogenous IFN-gamma during the effector phase, an anti-IFN-gamma monoclonal antibody (3 mg/time) was injected on days 3 and 4.
RESULTS: Injection of IFN-gamma into actively immunised rats suppressed eosinophilic infiltration but not infiltration of mononuclear cells. In contrast, neither IFN-gamma nor anti-IFN-gamma affected EC in passively immunised rats.
CONCLUSION: IFN-gamma is a suppressive cytokine for the development of EC and exerts this suppressive effect during the induction phase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234900      PMCID: PMC1771302          DOI: 10.1136/bjo.86.10.1166

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

Review 1.  Interferon activation and innate immunity.

Authors:  C Le Page; P Génin; M G Baines; J Hiscott
Journal:  Rev Immunogenet       Date:  2000

2.  Mechanism for maintenance of dominant T helper 1 immune responses in Lewis rats.

Authors:  S Sakamoto; A Fukushima; A Ozaki; H Ueno; M Kamakura; T Taniguchi
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

3.  Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC).

Authors:  O Yoshida; H Yoshida; H Iwamoto; K Nishino; A Fukushima; H Ueno
Journal:  Curr Eye Res       Date:  1999-02       Impact factor: 2.424

4.  Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus.

Authors:  Silvia Bozza; Roberta Gaziano; Antonio Spreca; Angela Bacci; Claudia Montagnoli; Paolo di Francesco; Luigina Romani
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 5.  Allergic conjunctivitis.

Authors:  P C Donshik
Journal:  Int Ophthalmol Clin       Date:  1988

6.  Gold is a T cell polyclonal activator in BN and LEW rats but favors IL-4 expression only in autoimmune prone BN rats.

Authors:  M Savignac; A Badou; C Delmas; J F Subra; S De Cramer; P Paulet; G Cassar; P Druet; A Saoudi; L Pelletier
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

7.  The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis.

Authors:  M T Magone; S M Whitcup; A Fukushima; C C Chan; P B Silver; L V Rizzo
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

8.  Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen.

Authors:  H Iwamoto; K Nishino; T M Magone; S M Whitcup; O Yoshida; H Yoshida; A Ozaki; A Fukushima; H Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-04       Impact factor: 3.117

9.  The role of IFN-gamma in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity.

Authors:  A Wensky; M C Marcondes; J J Lafaille
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

10.  Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats.

Authors:  A Ozaki; A Fukushima; K Fukata; H Ueno
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

View more
  10 in total

1.  Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis.

Authors:  Akemi Ozaki; Atsuki Fukushima; Kazuyo Fukata; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-04       Impact factor: 3.117

2.  Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.

Authors:  A Fukushima; T Sumi; K Fukuda; N Kumagai; T Nishida; H Yagita; H Ueno
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

Review 3.  T helper subsets in allergic eye disease.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

4.  Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.

Authors:  A Fukushima; T Yamaguchi; M Azuma; H Yagita; H Ueno
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

5.  Th1- and Th2-type cytokines in chronic ocular allergy.

Authors:  Andrea Leonardi; Iva A Fregona; Mario Plebani; Antonio G Secchi; Virginia L Calder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

6.  IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.

Authors:  Shana M Coley; Mandy L Ford; Samantha C Hanna; Maylene E Wagener; Allan D Kirk; Christian P Larsen
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

7.  Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.

Authors:  Atsuki Fukushima; Tomoko Yamaguchi; Tamaki Sumi; Ken Fukuda; Naoki Kumagai; Teruo Nishida; Masaru Takeuchi; Osamu Taguchi; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.535

Review 8.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

Review 9.  New Insights into the Role of PD-1 and Its Ligands in Allergic Disease.

Authors:  Miguel Angel Galván Morales; Josaphat Miguel Montero-Vargas; Juan Carlos Vizuet-de-Rueda; Luis M Teran
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

10.  Role of Programmed Cell Death Protein-1 and Lymphocyte Specific Protein Tyrosine Kinase in the Aryl Hydrocarbon Receptor- Mediated Impairment of the IgM Response in Human CD5+ Innate-Like B Cells.

Authors:  Jiajun Zhou; Lance K Blevins; Robert B Crawford; Norbert E Kaminski
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.